<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1355004</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2024.1355004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Near-infrared light-heatable platinum nanozyme for synergistic bacterial inhibition</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1355004">10.3389/fbioe.2024.1355004</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Xue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2308622/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhu</surname>
<given-names>Weisheng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Nan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xiangfan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Suling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Mengting</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Zhijun</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1461374/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hu</surname>
<given-names>Guixian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Agro-product Safety and Nutrition</institution>, <institution>Zhejiang Academy of Agricultural Sciences</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Information Traceability for Agricultural Products</institution>, <institution>Ministry of Agriculture and Rural Affairs of China</institution>, <addr-line>Hangzhou</addr-line>, <addr-line>Zhejiang</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Key Laboratory of Surface &#x26; Interface Science of Polymer Materials of Zhejiang Province</institution>, <institution>School of Chemistry and Chemical Engineering</institution>, <institution>Zhejiang Sci-Tech University</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Pharmacy</institution>, <institution>Taihe Hospital</institution>, <institution>Hubei University of Medicine</institution>, <addr-line>Shiyan</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>College of Pharmacy</institution>, <institution>Hubei University of Traditional Chinese Medicine</institution>, <addr-line>Wuhan</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University</institution>, <addr-line>Shengzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1362142/overview">Qitong Huang</ext-link>, Gannan Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1066844/overview">Zhijin Fan</ext-link>, Sun Yat-sen University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2608543/overview">Ming Hu</ext-link>, Nanjing Tech University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhijun Zhang, <email>zjzhang@zstu.edu.cn</email>; Guixian Hu, <email>hugx_shiny@163.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1355004</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Li, Zhu, Zhou, Wang, Gao, Sun, Cao, Zhang and Hu.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Li, Zhu, Zhou, Wang, Gao, Sun, Cao, Zhang and Hu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The development of non-antibiotic strategies for bacterial disinfection is of great clinical importance. Among recently developed different antimicrobial strategies, nanomaterial-mediated approaches, especially the photothermal way and reactive oxygen species (ROS)-generating method, show many significant advantages. Although promising, the clinical application of nanomaterials is still limited, owing to the potential biosafety issues. Further improvement of the antimicrobial activity to reduce the usage, and thus reduce the potential risk, is an important way to increase the clinical applicability of antibacterial nanomaterials. In this paper, an antimicrobial nanostructure with both an excellent photothermal effect and peroxidase-like activity was constructed to achieve efficient synergistic antimicrobial activity. The obtained nano-antimicrobial agent (ZIF-8@PDA@Pt) can not only efficiently catalyze the production of ROS from H<sub>2</sub>O<sub>2</sub> to cause damage to bacteria but also convert the photon energy of near-infrared light into thermal energy to kill bacteria, and the two synergistic effects induced in a highly efficient antimicrobial activity. This study not only offers a new nanomaterial with efficient antibacterial activity but also proposes a new idea for constructing synergistic antibacterial properties.</p>
</abstract>
<kwd-group>
<kwd>nanozyme</kwd>
<kwd>metal&#x2013;organic framework</kwd>
<kwd>photothermal effect</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>bacterial inhibition</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Agriculture Research System of China<named-content content-type="fundref-id">10.13039/501100010203</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nanobiotechnology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>Bacterial infection is a serious threat to global health, which is estimated to be the second leading cause of death worldwide, accounting for one in eight of all deaths in 2019 (<xref ref-type="bibr" rid="B10">Ikuta et al., 2022</xref>). Antibiotics, also known as antimicrobials, are the most commonly used treatment for bacterial infections. Antibiotics are a class of secondary metabolites with antipathogenic or other activities produced by microorganisms or higher plants and animals, which have shown high activity against bacterial infections. However, bacteria develop resistance to antibiotics over time, and the problem of bacterial resistance is growing due to the misuse of antibiotics. It is estimated that more than 1.2 million people&#x2014;and potentially millions more&#x2014;died globally a year as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate, to date, of the AMR) (<xref ref-type="bibr" rid="B17">Murray et al., 2022</xref>). Unfortunately, the rate of development of new antibiotics is much slower than the rate of emergence of bacterial resistance. In addition, the use of antibiotics for anti-infective therapy is prone to side effects such as liver damage and kidney injury. Thus, the development of novel antimicrobial strategies to reduce the use of antibiotics is of great clinical importance.</p>
<p>Many different new antimicrobial strategies have been reported in recent years (<xref ref-type="bibr" rid="B21">Sun et al., 2020</xref>; <xref ref-type="bibr" rid="B19">Niu et al., 2021a</xref>; <xref ref-type="bibr" rid="B20">Niu et al., 2021b</xref>; <xref ref-type="bibr" rid="B3">Du et al., 2021</xref>; <xref ref-type="bibr" rid="B30">Zhang et al., 2021</xref>; <xref ref-type="bibr" rid="B13">Li et al., 2022a</xref>; <xref ref-type="bibr" rid="B12">Li et al., 2022b</xref>; <xref ref-type="bibr" rid="B5">Fu et al., 2022</xref>; <xref ref-type="bibr" rid="B6">Guo et al., 2022</xref>; <xref ref-type="bibr" rid="B22">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="B25">Wu et al., 2023</xref>). Among them, nanomaterial-mediated antimicrobial strategies show more significant advantages, including easy material synthesis, being less susceptible to bacterial resistance, and a high bacterial killing efficiency. In these strategies, nanomaterials usually play the role of mediators of energy or material conversion. Typically, nanomaterials can convert the energy of external physical stimuli into thermal energy that can directly damage the bacterial structure (<xref ref-type="bibr" rid="B14">Liu et al., 2022a</xref>; <xref ref-type="bibr" rid="B8">Hu et al., 2022</xref>). The photothermal antimicrobial strategy is such an energy conversion-based bacterial disinfection method, which is favored for its high killing efficiency and spatial and temporal controllability (<xref ref-type="bibr" rid="B7">Han et al., 2020</xref>). The photothermal effect is a property of materials that can harvest and transfer the photon energy from irradiated light to heat energy, which is promising for wide applications (<xref ref-type="bibr" rid="B24">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="B26">Wu and Yeow, 2022</xref>; <xref ref-type="bibr" rid="B29">Zeng et al., 2022</xref>; <xref ref-type="bibr" rid="B4">Fan et al., 2023</xref>; <xref ref-type="bibr" rid="B9">Huang et al., 2023</xref>; <xref ref-type="bibr" rid="B11">Jiao et al., 2023</xref>; <xref ref-type="bibr" rid="B28">Yue et al., 2023</xref>; <xref ref-type="bibr" rid="B31">Zhao et al., 2023</xref>; <xref ref-type="bibr" rid="B32">Zhu et al., 2023</xref>). In the photothermal antimicrobial strategy, nanomaterials with photothermal conversion efficiency, such as graphene, Fe<sub>3</sub>O<sub>4</sub>, polydopamine (PDA), and gold nanostructures, can efficiently convert the photon energy of near-infrared light into thermal energy to achieve efficient killing of different types of bacteria (<xref ref-type="bibr" rid="B18">Niu et al., 2018</xref>; <xref ref-type="bibr" rid="B23">Wang et al., 2022</xref>). In addition, nanomaterials with enzyme-like activity can convert endogenous or exogenous chemicals into high-energy reactive oxygen species (ROS) to cause bacterial casualties (<xref ref-type="bibr" rid="B1">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B15">Liu et al., 2022b</xref>; <xref ref-type="bibr" rid="B2">Dorma Momo et al., 2022</xref>). For example, nanoenzymes such as graphene oxide and carbon dots can catalyze the production of ROS from highly expressed or exogenous H<sub>2</sub>O<sub>2</sub> at the site of bacterial infection to cause the destruction of bacterial nucleic acids and proteins and thus lead to bacterial death. Nanomaterial-mediated antimicrobial strategies undoubtedly offer unlimited possibilities for replacing the use of antibiotics (<xref ref-type="bibr" rid="B16">Makabenta et al., 2021</xref>; <xref ref-type="bibr" rid="B27">Xie et al., 2023</xref>). Nevertheless, the clinical application of nanomaterials is still very limited at present as the biosafety issues of their clinical application are yet to be fully evaluated. Further improvement of antimicrobial activity to reduce the usage, and thus reduce the potential risk, is an important way to increase the clinical applicability of antibacterial nanomaterials.</p>
<p>In this paper, an antimicrobial nanostructure with both the photothermal effect and peroxidase-like activity was constructed to combine the photothermal antimicrobial and free radical antimicrobial strategies to achieve efficient synergistic antimicrobial activity (<xref ref-type="scheme" rid="sch1">Scheme 1</xref>). ZIF-8, a frequently used metal&#x2013;organic framework (MOF) in biomedical research, was chosen as the nanocarrier. A PDA layer with an excellent photothermal effect was encapsulated on the surface of ZIF-8 by <italic>in situ</italic> polymerization, and then, platinum nanoparticles (PtNPs) with peroxidase-like activity were allowed to grow on the PDA layer. The obtained nano-antimicrobial agent (ZIF-8@PDA@Pt) can not only efficiently catalyze the production of ROS from H<sub>2</sub>O<sub>2</sub> to cause damage to bacteria but also convert photon energy of the near-infrared light into thermal energy to kill bacteria, and the two synergistic effects induced in a highly efficient antimicrobial activity.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Synthesis of ZIF-8@PDA@Pt</title>
<p>ZIF-8 was synthesized through a specific coordination reaction between zinc ions and 2-methylimidazole. In a typical experiment, 1.069&#xa0;g Zn(NO<sub>3</sub>)<sub>2</sub>&#xb7;6H<sub>2</sub>O was dissolved in 15&#xa0;mL of DMF-MeOH mixture (v/v &#x3d; 4:1) as solution <bold>1</bold>, 1.161&#xa0;g of 2-methylimidazole was dissolved in 10&#xa0;mL of DMF-MeOH (v/v &#x3d; 4:1) as solution <bold>2</bold>; then, solution <bold>1</bold> was added to solution <bold>2</bold> and kept stirring vigorously overnight. Subsequently, the milky product was collected by centrifugation at 14,000&#xa0;rpm for 10&#xa0;min, rinsed with methanol and ultrapure water two times, and then dried at 80&#xb0;C overnight to obtain ZIF-8 for subsequent experiments.</p>
<p>ZIF-8@PDA was attained by a self-polymerization reaction of dopamine. A measure of 20&#xa0;mg ZIF-8 we prepared was dissolved in the Tris-HCl buffer solution (pH 8.5, 50&#xa0;mM) with the assistance of sonicating for 2&#xa0;min; then, 10&#xa0;mg dopamine was added to the above solution, and the mixture was violently stirred for 90&#xa0;min. Thereafter, the obtained black mixture was collected by centrifugation at 14,000&#xa0;rpm for 10&#xa0;min, washed with water three times, and eventually concentrated to 2&#xa0;mL for later use.</p>
<p>Subsequently, ZIF-8@PDA@Pt was gained by an <italic>in situ</italic> reduction method using ZIF-8@PDA as a precursor. A measure of 2&#xa0;mL of ZIF-8@PDA we prepared previously was added to 7,740&#xa0;&#x3bc;L ultrapure water and sonicated for 2&#xa0;min; then, 260&#xa0;&#x3bc;L of H<sub>2</sub>PtCl<sub>4</sub> (19.2&#xa0;mM) was added and sonicated for 5&#xa0;min; in a rapid subsequence, 500&#xa0;&#x3bc;L of the refresh NaBH<sub>4</sub> solution (1&#xa0;M) was added to the above solution under drastic magnetic stirring for 1&#xa0;h. Finally, the mixture was collected by centrifugation at 14,000&#xa0;rpm for 10&#xa0;min and ultimately washed with ultrapure water three times to obtain ZIF-8@PDA@Pt.</p>
</sec>
<sec id="s2-2">
<title>2.2 Measurement of peroxidase-mimic activity</title>
<p>The peroxidase-mimic activity of ZIF-8@PDA@Pt was measured by a classical chromogenic reaction using TMB as the substrate. In brief, 5&#xa0;&#x3bc;L TMB (80&#xa0;mM), 50&#xa0;mL H<sub>2</sub>O<sub>2</sub> (10&#xa0;mM), and 50&#xa0;&#x3bc;L ZIF-8@PDA@Pt (0.2&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were added to the phosphate buffer solution (pH 5.0, 20&#xa0;mM) with a total volume of 0.5&#xa0;mL, respectively. Subsequently, the mixture was incubated for 5&#xa0;min, and the absorbance at 652&#xa0;nm was recorded simultaneously by an ultraviolet-visible spectrum. o-Phenylenediamine (OPD) was employed as a chromogenic substrate to further evaluate the peroxidase-mimic activity of ZIF-8@PDA@Pt. Typically, 5&#xa0;&#x3bc;L OPD (50&#xa0;mM), 50&#xa0;mL H<sub>2</sub>O<sub>2</sub> (10&#xa0;mM), and 50&#xa0;&#x3bc;L ZIF-8@PDA@Pt (0.2&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were added to the phosphate buffer solution (pH 5.0, 20&#xa0;mM) with a total volume of 0.5&#xa0;mL, respectively. Subsequently, the mixture was incubated for 5&#xa0;min, and the absorbance at 425&#xa0;nm was recorded simultaneously by an ultraviolet-visible spectrum.</p>
</sec>
<sec id="s2-3">
<title>2.3 Catalytic kinetic assay</title>
<p>The kinetic assay of the peroxidase-mimic activity of ZIF-8@PDA@Pt was conducted by changing the concentration of H<sub>2</sub>O<sub>2</sub> or TMB. The reaction was performed under an optimized condition (pH 5.0, 37&#xb0;C). Typically, 2&#xa0;&#x3bc;L TMB (80&#xa0;mM), H<sub>2</sub>O<sub>2</sub> with different concentrations, and 20&#xa0;&#x3bc;L ZIF-8@PDA@Pt (0.2&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were added to a phosphate buffer solution (pH 5.0, 20&#xa0;mM) with a total volume of 0.2&#xa0;mL; then, the absorbance at 652&#xa0;nm was recorded in time at a time scanning window. The real-time velocity of the reaction was converted by the Beer&#x2013;Lambert Law, A &#x3d; &#x3b5;bC, where b is the path length (1&#xa0;cm) and <italic>&#x3b5;</italic> is the molar absorption coefficient of oxidized TMB (39,000&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>). Corresponding parameters of kinetics were calculated according to the Michaelis&#x2013;Menten equation and Lineweaver&#x2013;Burk plot:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
<mml:mfrac>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>K</mml:mi>
</mml:mrow>
<mml:mi mathvariant="normal">m</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>K</mml:mi>
</mml:mrow>
<mml:mi mathvariant="normal">m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>S</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x2b;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>V</italic>
<sub>
<italic>0</italic>
</sub> is the initial reaction rate and [<italic>S</italic>] is the concentration of the substrate (H<sub>2</sub>O<sub>2</sub> or TMB).</p>
</sec>
<sec id="s2-4">
<title>2.4 Detection of ROS generation</title>
<p>Terephthalic acid (TA) was used as a fluorescent probe to validate the generation of &#x2022;OH. Typically, TA (0.5&#xa0;mM), H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM), and ZIF-8@PDA@Pt (0.1&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were first mixed into PBS (pH &#x3d; 5.0, 20&#xa0;mM) and incubated in dark for 2&#xa0;h, and then were taken for fluorescent spectra characterization. In addition, 1,3-diphenylisobenzofuran (DPBF) and 9,10-anthracenediyl-bis(methylene)-dimalonic acid (ABDA) were used as probes to assay O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup> and <sup>1</sup>O<sub>2</sub>, respectively. Specifically, DPBF (1&#xa0;mM), H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM), and ZIF-8@PDA@Pt (0.1&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were incubated together in PBS (pH &#x3d; 5.0, 20&#xa0;mM) for 5&#xa0;min; meanwhile, the absorbance at 421&#xa0;nm was recorded every 30&#xa0;s. ABDA (0.05&#xa0;mM), H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM), and ZIF-8@PDA@Pt (0.1&#xa0;mg&#xa0;mL<sup>&#x2212;1</sup>) were incubated together in PBS (pH &#x3d; 5.0, 20&#xa0;mM) for a while and then were taken to measure the change of absorbance using UV spectra.</p>
</sec>
<sec id="s2-5">
<title>2.5 Determination of the photothermal property</title>
<p>The photothermal property of ZIF-8@PDA@Pt was determined using an 808-nm laser, and the real-time temperature was observed with a thermal imaging camera. In brief, ZIF-8@PDA@Pt aqueous dispersion with different concentrations (0, 20, 40, 60, 80, 100, and 120&#xa0;ug&#xa0;mL<sup>&#x2212;1</sup>) was radiated under 808&#xa0;nm (1.0&#xa0;W&#xa0;cm<sup>&#x2212;1</sup>) for 5&#xa0;min. Concurrently, the temperature of the ZIF-8@PDA@Pt aqueous dispersion was recorded every 30&#xa0;s. Thereafter, the heating&#x2013;cooling curves were obtained to calculate the photothermal conversion efficiency in accordance with below equations:<disp-formula id="e1">
<mml:math id="m3">
<mml:mrow>
<mml:mi mathvariant="normal">&#x3b7;</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mi>S</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>max</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2010;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>T</mml:mi>
</mml:mrow>
<mml:mtext>surr</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2010;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">Q</mml:mi>
</mml:mrow>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2010;</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>10</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2010;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mn>808</mml:mn>
</mml:msub>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
<disp-formula id="e2">
<mml:math id="m4">
<mml:mrow>
<mml:msub>
<mml:mi>&#x3c4;</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>m</mml:mi>
<mml:mi>d</mml:mi>
</mml:msub>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>d</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mi>S</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
<disp-formula id="e3">
<mml:math id="m5">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">Q</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>h</mml:mi>
<mml:mi>S</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mrow>
<mml:mi>max</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mo>,</mml:mo>
<mml:mtext>water</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2010;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>T</mml:mi>
</mml:mrow>
<mml:mtext>surr</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>where <italic>&#x3b7;</italic> is the photothermal conversion efficiency. The value of <italic>&#x3c4;</italic>
<sub>
<italic>s</italic>
</sub> was obtained by linearly fitting the plot of the cooling time t versus the term -Ln&#x3b8;, <italic>hS</italic> was obtained from Eq. <xref ref-type="disp-formula" rid="e2">2</xref>, <italic>m</italic>
<sub>
<italic>d</italic>
</sub> is the mass of the solution (0.2&#xa0;g), <italic>C</italic>
<sub>
<italic>d</italic>
</sub> is the heat capacity of water (4.2&#xa0;J&#xa0;g<sup>&#x2212;1</sup>&#xb0;C<sup>&#x2212;1</sup>), Q<sub>0</sub> was obtained from Eq. <xref ref-type="disp-formula" rid="e3">3</xref>, <italic>T</italic>
<sub>max</sub> is the equilibrium temperature (61.5&#xb0;C), <italic>T</italic>
<sub>max, water</sub> is the maximum temperature of water (29.1&#xb0;C), and <italic>T</italic>
<sub>surr</sub> is the surrounding ambient temperature (28.3&#xb0;C). <italic>I</italic> is the incident light power (0.8&#xa0;W&#xa0;cm<sup>&#x2212;2</sup>), and A<sub>808</sub> is the absorbance of the ZIF-8@PDA@Pt aqueous dispersion (120&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) at 808&#xa0;nm (0.17).</p>
</sec>
<sec id="s2-6">
<title>2.6 Antibacterial activity test</title>
<p>
<italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> were selected as Gram-positive and Gram-negative model strains to estimate the antibacterial activity of ZIF-8@PDA@Pt, respectively. Mono colonies of <italic>S</italic>. <italic>aureus</italic> and <italic>E. coli</italic> on a solid agar plate were first transferred to 2&#xa0;mL of the lysogeny broth (LB) medium and shaken at 37&#xb0;C for 12&#xa0;h at 150&#xa0;rpm. Four different groups were set in this typical procedure, containing I: Control, II: H<sub>2</sub>O<sub>2</sub>, III: ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub>, and IV ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub> &#x2b; NIR. In addition, 0.3 was selected as the initial optical density of bacteria at OD<sub>600&#xa0;nm</sub>. In addition, the final concentration of H<sub>2</sub>O<sub>2</sub> and ZIF-8@PDA@Pt in the incubation system was 2&#xa0;mM and 100&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>, respectively. All groups were incubated at 37&#xb0;C for 20&#xa0;min. Thereafter, the bacterial suspensions were moved to the solid medium by the spread plate method and cultured at 37&#xb0;C for another for 12&#xa0;h. Finally, all experimental groups were taken for imaging and counting. Each assay was performed in triplicates.</p>
</sec>
<sec id="s2-7">
<title>2.7 Live/dead bacterial staining</title>
<p>Bacterial suspensions treated with the different experimental conditions were first centrifuged for 5&#xa0;min (4,000&#xa0;rpm), followed by washing two times using 0.85% NaCl solutions. Afterward, the above bacterial suspensions were stained with SYTO 9 and propidium iodide and then observed with a fluorescent microscope.</p>
</sec>
<sec id="s2-8">
<title>2.8 Cell viability assay</title>
<p>HSF cells were performed for the biocompatibility assay of ZIF-8@PDA@Pt. At first, the HSF cells were cultured in a 96-well plate (8,000 cells per well) at 37&#xb0;C for 24&#xa0;h; then, ZIF-8@PDA@Pt with different concentrations (0, 25, 50, 100, 150, and 200&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) were added to the above medium and incubated for another 24&#xa0;h at 37&#xb0;C. Thereafter, 10&#xa0;&#x3bc;L of the MTT solution was added to every well. After 4&#xa0;h, the medium was extracted and 150&#xa0;&#x3bc;L of DMSO was added to every well. The cell viability was assayed using a microplate reader.</p>
<fig id="sch1" position="float">
<label>SCHEME 1</label>
<caption>
<p>Schematic illustration of the synthesis of ZIF-8@PDA@Pt and the principle of bacterial killing.</p>
</caption>
<graphic xlink:href="FBIOE_fbioe-2024-1355004_wc_sch1.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Synthesis and characterization of ZIF-8@PDA@Pt</title>
<p>ZIF-8@PDA@Pt was prepared through <italic>in situ</italic> reduction of H<sub>2</sub>PtCl<sub>4</sub> in the presence of a specific precursor obtained by modifying a layer of polydopamine on the surface of ZIF-8. To begin with, ZIF-8 was conducted by a specific coordination reaction between zinc ions and 2-methylimidazole. Afterward, a layer of PDA was modified on ZIF-8, relying on the self-polymerization reaction of dopamine under a weak alkaline environment to obtain ZIF@PDA. Eventually, Pt NPs were localized on ZIF@PDA by <italic>in situ</italic> reduction to obtain the nanozyme ZIF-8@PDA@Pt. TEM and SEM were primarily employed to characterize the morphology during the formation of ZIF-8@PDA@Pt (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>); it is clearly to be observed that ZIF-8 possesses the regular rhombic dodecahedral morphology while a thin layer at the edge of ZIF-8 was noticed after modifying polydopamine, verifying the formation of ZIF-8@PDA. In addition, it can be seen that ultra-small Pt NPs were distributed on ZIF-8@PDA. In addition, energy-dispersive X-ray spectrometry (EDX) mapping was recruited to characterize the elemental distribution of ZIF-8@PDA@Pt nanozyme (<xref ref-type="fig" rid="F1">Figure 1C</xref>). The results presented the homogeneous distributions of elements C, N, O, Zn, and Pt in ZIF-8@PDA@Pt, demonstrating the successful loading of Pt NPs onto the ZIF-8@PDA platform. Meanwhile, ZIF-8@PDA@Pt exhibits a size of approximately 650&#xa0;nm, according to the dynamic light scattering analysis (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>TEM <bold>(A)</bold> and SEM <bold>(B)</bold> images of the nanostructures, and the elemental mapping <bold>(C)</bold> and size distribution <bold>(D)</bold> of ZIF-8@PDA@Pt. XRD patterns <bold>(E)</bold> and UV-vis spectra <bold>(F)</bold> of these nanoparticles.</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g001.tif"/>
</fig>
<p>Additionally, in order to explore the chemical structure and composition, we executed X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and UV-vis spectra. As illustrated in <xref ref-type="fig" rid="F1">Figure 1E</xref>, the pattern of ZIF-8 exhibits several typical characteristic peaks at around 7.46&#xb0;, 10.52&#xb0;,12.87&#xb0;, and 18.27&#xb0;, ascribing to (001), (002), (112), and (222) crystal faces, respectively, which conforms its regular crystal structure. Of note, the main diffraction peaks of ZIF-8 remained after modifying PDA and loading Pt NPs. In particular, the XRD diffraction of ZIF-8@PDA@Pt presents an unmistakable peak at 39.5&#xb0; in line with the (111) facet of the Pt crystal (JCPDS No. 04-0802), which further confirmed the successful preparation of ZIF-8@PDA@Pt. The UV-vis spectra were also measured and are presented in <xref ref-type="fig" rid="F1">Figure 1F</xref>. It can be noted that two typical peaks at approximately 234 and 300&#xa0;nm in ZIF-8 and ZIF-8@PDA assigned to the <italic>&#x3c0;</italic>-<italic>&#x3c0;</italic>&#x2a; transition of the conjugated system from the imidazole structure and <italic>n</italic>-<italic>&#x3c0;</italic>&#x2a; transition of polydopamine, respectively. Nonetheless, the peak at approximately 300&#xa0;nm is not well-preserved in ZIF-8@PDA@Pt, which may be caused within the loading of Pt NPs. In addition, XPS was performed to characterize the element constitution of ZIF-8@PDA@Pt (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). The element contents of C, N, O, Zn, and Pt are 53.08%, 9.55%, 25.03%, 10.72%, and 1.62%, respectively. More precisely, in the high-resolution spectrum of Pt 4f, the peaks located at 71.0, 72.2, 74.2, and 75.5&#xa0;eV are ascribed to Pt<sup>0</sup> 4f 7/2, Pt<sup>4&#x2b;</sup> 4f 7/2, Pt<sup>0</sup> 4f 5/2, and Pt<sup>4&#x2b;</sup> 4f 5/2 binding energies, respectively, which are analogous to the majority of Pt NPs. Likewise, several typical peaks at approximately 284.5, 286.2, and 288.3&#xa0;eV can be identified from the high-resolution C1s spectrum, which are assigned to C-C, C-N/C-O, and C&#x3d;C groups, respectively. It can be observed that three peaks are located at 398.2, 399.3, and 400.7&#xa0;eV from the N 1s spectrum, corresponding to pyridinic N, pyrrolic N, and graphitic N, respectively. Comparably, the curve-fitted O1s spectrum exhibits two peaks 531.3 and 533.1&#xa0;eV, attributing to C-O and C-OH groups, respectively. In addition, the high-resolution Zn 2p spectra of ZIF-8@PDA@Pt present two peaks placed at 1022.3 and 1045.3&#xa0;eV belonging to Zn 2p 1/2 and Zn 2p 2/3 of zinc oxide, respectively. In combination with the above results, it is believed that ZIF-8@PDA@Pt was successfully prepared.</p>
</sec>
<sec id="s3-2">
<title>3.2 Catalytic performance of ZIF-8@PDA@Pt</title>
<p>After successful synthesis of the ZIF-8@PDA@Pt nanoparticles, we then investigated its peroxidase (POD)-like activity using 3,3&#x2032;,5,5&#x2032;-tetramethylbenzidine (TMB) as the chromogenic substrate and H<sub>2</sub>O<sub>2</sub> as the catalysis substrate. As shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>, without ZIF-8@PDA@Pt, H<sub>2</sub>O<sub>2</sub> cannot cause any color change in the TMB solution. However, in the presence of ZIF-8@PDA@Pt and H<sub>2</sub>O<sub>2</sub>, the color of the TMB solution significantly changed to dark blue (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;2iv</xref>), indicating the strong POD-like activity of ZIF-8@PDA@Pt. In this catalytic system, ZIF-8@PDA@Pt may catalyze H<sub>2</sub>O<sub>2</sub> to produce ROS, which can oxidize TMB to generate blue color. Notably, without H<sub>2</sub>O<sub>2</sub>, the nanozyme ZIF-8@PDA@Pt can also cause an obvious change in the color of the TMB solution (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;2iii</xref>), demonstrating that the nanozyme also possesses oxidase-like activity. The enzyme-like activity of ZIF-8@PDA@Pt was also demonstrated from the absorbance change of the TMB solution (<xref ref-type="fig" rid="F2">Figure 2B</xref>). To further evaluate the enzymatic activities of the nanozyme ZIF-8@PDA@Pt, the catalytic dynamics was investigated. We carried out a steady-state kinetic study to obtain the rate constants by varying the concentration of TMB with a constant concentration of H<sub>2</sub>O<sub>2</sub> or <italic>vice versa</italic>. The Michaelis constant (<italic>K</italic>
<sub>
<italic>m</italic>
</sub>) and maximum reaction rate (<italic>V</italic>
<sub>max</sub>) were calculated from the fitted Michaelis&#x2012;Menten curves and Lineweaver&#x2012;Burk double reciprocal plots (<xref ref-type="fig" rid="F2">Figures 2C&#x2013;F</xref>). As a comparison, the obtained <italic>K</italic>
<sub>
<italic>m</italic>
</sub> and <italic>V</italic>
<sub>max</sub> of ZIF-8@PDA@Pt and other catalysts including the natural enzyme HRP and Fe<sub>3</sub>O<sub>4</sub> nanozymes are listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. <italic>K</italic>
<sub>
<italic>m</italic>
</sub> indicates the enzyme affinity toward substrates, and <italic>V</italic>
<sub>max</sub> defines the maximal catalytic capacity of an enzyme under specified conditions. Generally, a smaller <italic>K</italic>
<sub>
<italic>m</italic>
</sub> demonstrates higher affinity, while the higher <italic>V</italic>
<sub>max</sub> refers to the better catalytic capability. These results indicated that the obtained nanozyme ZIF-8@PDA@Pt shows better catalytic performance than the classical POD nanozyme Fe<sub>3</sub>O<sub>4</sub>, and some parameters are even significantly better than natural enzymes. For example, <italic>K</italic>
<sub>
<italic>m</italic>
</sub> of ZIF-8@PDA@Pt was 0.062&#xa0;mM for TMB, which is much lower than that of HRP and Fe<sub>3</sub>O<sub>4</sub>, indicating that ZIF-8@PDA@Pt has the highest enzyme affinity toward TMB. Moreover, ZIF-8@PDA@Pt also shows the highest <italic>V</italic>
<sub>max</sub> values. These results demonstrated that the obtained ZIF-8@PDA@Pt possesses excellent POD-like activity, also implying the strong ROS generation ability of the ZIF-8@PDA@Pt&#x2013;H<sub>2</sub>O<sub>2</sub> system.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Images and <bold>(B)</bold> UV-vis absorption spectra of the TMB solution under different conditions (i: TMB, ii: TMB &#x2b; H<sub>2</sub>O<sub>2</sub>, iii: ZIF-8@PDA@Pt &#x2b; TMB, and iv: ZIF-8@PDA@Pt &#x2b; TMB &#x2b; H<sub>2</sub>O<sub>2</sub>). <bold>(C)</bold> Michaelis&#x2013;Menten curve under 0.8&#xa0;mM TMB and various concentrations of H<sub>2</sub>O<sub>2</sub>. <bold>(D)</bold> Lineweaver&#x2013;Burk plot for H<sub>2</sub>O<sub>2</sub>. <bold>(E)</bold> Michaelis&#x2013;Menten curve under 1&#xa0;mM H<sub>2</sub>O<sub>2</sub> with various concentrations of TMB. <bold>(F)</bold> Lineweaver&#x2013;Burk plot for TMB.</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g002.tif"/>
</fig>
<p>To further verify the ability of ZIF-8@PDA@Pt to catalyze the production of different free radicals from H<sub>2</sub>O<sub>2</sub>, terephthalic acid (TA), 1,3-diphenylisobenzofuran (DPBF), and 9,10-anthracenediyl-bis(methylene)-dimalonic acid (ABDA) were chose as the indicators for the sensing of hydroxyl radical (&#x2022;OH), O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup> (superoxide anion), and singlet oxygen (<sup>1</sup>O<sub>2</sub>), respectively. TA is a non-fluorescent molecule that can be oxidized by &#x2022;OH to generated blue fluorescence. DPBF is a fluorescent molecule which possesses a specific reactivity toward <sup>1</sup>O<sub>2</sub> and O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup>, forming an endoperoxide that can decompose to give 1,2-dibenzoylbenzene. This decomposition of DPBF by <sup>1</sup>O<sub>2</sub> and O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup> can be measured by the decrease in the absorbance intensity of DPBF at 412&#xa0;nm. ABDA is a highly selective probe for singlet oxygen <sup>1</sup>O<sub>2</sub>, which can be oxidized with the decrease in the absorbance intensity. As shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, in the solution with the probes and H<sub>2</sub>O<sub>2</sub>, the presence of ZIF-8@PDA@P can induce significant sensing signals of &#x2022;OH, O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup>, and <sup>1</sup>O<sub>2</sub>. These results strongly demonstrated that ZIF-8@PDA@Pt can catalyze the production of different free radical species from H<sub>2</sub>O<sub>2</sub>, which is very important for bacterial disinfection.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The spectral signals measured by using different ROS probes, TA <bold>(A)</bold>, DPBF <bold>(B)</bold> and ABDA <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Photothermal effect of ZIF-8@PDA@Pt</title>
<p>As illustrated in the UV-vis spectra of <xref ref-type="fig" rid="F1">Figure 1F</xref>, ZIF-8@PDA@Pt presents broad and intense adsorption from the ultraviolet to NIR region, manifesting ZIF-8@PDA@Pt possesses considerable photothermal conversion potential. So as to validate the supposition, the photothermal property of ZIF-8@PDA@Pt was primarily investigated, where the aqueous dispersions of ZIF-8@PDA@Pt with different concentrations were irradiated under an 808-nm NIR laser. Simultaneously, the real-time temperatures were recorded by a thermal imaging camera. It can be observed from <xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref> that the temperature of the aqueous solution lifted promptly with the augment of the concentration of ZIF-8@PDA@Pt and the prolongation of irradiation time. Indeed, the constant arising trend of the curve implied that ZIF-8@PDA@Pt exhibits supreme photostability under the irradiation of the NIR laser. It can also be visually discovered from the quantitative data that the temperature of the ZIF-8@PDA@Pt solution (120&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) elevated rapidly from 28.5&#xb0;C to 61.5&#xb0;C within 5&#xa0;min of irradiation, while the temperature of water only raised by 0.8&#xb0;C under the same conditions. Such a result elucidated ZIF-8@PDA@Pt can serve as a remarkable photothermal agent. Hence, we further calculated the photothermal conversion efficiency of ZIF-8@PDA@Pt in line with a method reported previously (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>), where it can be up to 65.4% to our surprise, and this excellent property just met the experimental results we obtained as well, where the real-time temperature of the NIR-irradiated ZIF-8@PDA@Pt aqueous solution can reach up to 61.5&#xb0;C in a short time.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Thermal imaging <bold>(A)</bold>, temperature variation curve <bold>(B)</bold>, and corresponding 3D surface graph <bold>(C)</bold> of ZIF-8@PDA@Pt with different concentrations under laser irradiation (0.8&#xa0;W) over time. <bold>(D)</bold> Temperature variation curve of the ZIF-8@PDA@Pt solution under different laser intensities over time (808&#xa0;nm, 120&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>).</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g004.tif"/>
</fig>
<p>In addition, it was found that ZIF-8@PDA@Pt presented a laser power-dependent behavior. As shown in <xref ref-type="fig" rid="F4">Figure 4D</xref>, the temperature of solutions at the same time nodes increased gradually along with the increase in laser power, denoting the laser power to be imperative to the photothermal conversion ability of ZIF-8@PDA@Pt. Afterward, the thermal stability of ZIF-8@PDA@Pt was estimated by photothermal performance cycle monitoring within four laser cycles. It can be noted from <xref ref-type="sec" rid="s10">Supplementary Figure S3</xref> that there were no unmistakable temperature fluctuations in the four photothermal cycles, demonstrating ZIF-8@PDA@Pt endows considerable photothermal stability. All above results certified that ZIF-8@PDA@Pt possessed excellent photothermal properties, which can support its application for sterilization.</p>
</sec>
<sec id="s3-4">
<title>3.4 Synergistic antibacterial effect of ZIF-8@PDA@Pt</title>
<p>Inspired by the superior enzymatic activity and photothermal property of ZIF-8@PDA@Pt, the <italic>in vitro</italic> synergistic antibacterial effect of ZIF-8@PDA@Pt against Gram-negative bacteria (<italic>E. coli</italic>) and Gram-positive bacteria (<italic>S. aureus</italic>) was assessed by the plate counting method. As shown in <xref ref-type="fig" rid="F5">Figure 5</xref>, H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM) alone cannot induce significant influence on the bacterial viability. However, in the presence of ZIF-8@PDA@Pt, the viabilities of both <italic>E. coli</italic> and <italic>S. aureus</italic> decreased to below 40%. The ROS generated form H<sub>2</sub>O<sub>2</sub> under the catalysis of ZIF-8@PDA@Pt would be responsible for this sharp decrease in the bacterial viability. Moreover, as expected, NIR irradiation greatly promoted the antibacterial efficiency of the ZIF-8@PDA@Pt/H<sub>2</sub>O<sub>2</sub> system, in which the bacterial viabilities decreased to below 3%. The viability of the treated bacteria was also investigated by a live/dead staining kit, which contains two dyes, SYTO 9 and propidium iodide (PI). SYTO 9 is a membrane-permeable dye that can give a green fluorescence to indicate the live cells due to the binding with bacterial nucleic acid. PI is also a nucleic acid-binding dye used to give a red fluorescence, which can only penetrate the damaged membrane of dead bacteria. As shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, upon treating with ZIF-8@PDA@Pt and H<sub>2</sub>O<sub>2</sub>, significant amount of dead bacteria was found in the fluorescence images, and almost all of the bacteria were killed when the ZIF-8@PDA@Pt/H<sub>2</sub>O<sub>2</sub> system was irradiated with the NIR light. This phenomenon was the same as that found in the plate counting experiments. These results clearly demonstrated the high synergistic antimicrobial activity of the nanozyme ZIF-8@PDA@Pt in the presence of H<sub>2</sub>O<sub>2</sub> and NIR light irradiation. Notably, the nanozyme also has good biocompatibility; in the MTT assay, over 90% of the HSF cells remain alive when in the incubation with 250&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup> of ZIF-8@PDA@Pt.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> Photographs of the colonies of <italic>E. coli</italic> and <italic>S. aureus</italic> treated under different conditions. alculated bacterial viabilities of C<italic>E. coli</italic> <bold>(B)</bold> and <italic>S. aureus</italic> <bold>(C)</bold> in <bold>(A)</bold>. I: Control, II: H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM), III: ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub>, and IV: ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub> &#x2b; NIR. (H<sub>2</sub>O<sub>2</sub> 2&#xa0;mM, ZIF-8@PDA@Pt 100&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>, NIR 808&#xa0;nm 0.8&#xa0;W 5&#xa0;min).</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g005.tif"/>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Fluorescent images of live/dead staining of bacteria upon different treatments. <bold>(A)</bold>: Control, <bold>(B)</bold>: H<sub>2</sub>O<sub>2</sub> (2&#xa0;mM), <bold>(C)</bold>: ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub>, and <bold>(D)</bold>: ZIF-8@PDA@Pt &#x2b; H<sub>2</sub>O<sub>2</sub> &#x2b; NIR. (H<sub>2</sub>O<sub>2</sub> 2&#xa0;mM, ZIF-8@PDA@Pt 100&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>, NIR 808&#xa0;nm 0.8&#xa0;W 5&#xa0;min).</p>
</caption>
<graphic xlink:href="fbioe-12-1355004-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In conclusion, a platinum nanozyme ZIF-8@PDA@Pt with high peroxidase-like activity was successfully synthesized. The catalytic activity is much higher than the classical nanozyme Fe<sub>3</sub>O<sub>4</sub>, and some parameters are even better than the natural enzyme HRP. The obtained nanozyme ZIF-8@PDA@Pt can efficiently promote the generation of different ROS from H<sub>2</sub>O<sub>2</sub>. Moreover, ZIF-8@PDA@Pt can harvest the photon energy from the NIR light to heating the solution. The combined excellent photothermal effect and peroxidase-like activity resulted in high synergistic antimicrobial activity of the nanozyme ZIF-8@PDA@Pt in the presence of H<sub>2</sub>O<sub>2</sub> and NIR light irradiation. The developed nano-antibacterial strategy is highly promising for wide applications, for example, wound infection treatment, antibacterial coatings for medical materials, preservation and protection of agricultural products, etc.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>; further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>XL: methodology, writing&#x2013;review and editing, investigation, and writing&#x2013;original draft. WZ: writing&#x2013;review and editing, investigation, methodology, and writing&#x2013;original draft. YZ: investigation, methodology, and writing&#x2013;review and editing. NW: investigation, methodology, and writing&#x2013;review and editing. XG: investigation, methodology, and writing&#x2013;original draft. SS: methodology and writing&#x2013;review and editing. MC: investigation and writing&#x2013;review and editing. ZZ: methodology, conceptualization, funding acquisition, supervision, writing&#x2013;original draft, and writing&#x2013;review and editing. GH: methodology, funding acquisition, supervision, and writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research received financial support from the National Natural Science Foundation of China (NSFC) (No. 22007083), China Agriculture Research System (CARS-29), and the Fundamental Research Funds of the Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University (No. SYY 2023B000004). The Program of Agricultural Product Quality Safety Risk Assessment (GJFP20210501).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2024.1355004/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2024.1355004/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Enzyme mimicry for combating bacteria and biofilms</article-title>. <source>Accounts Chem. Res.</source> <volume>51</volume>, <fpage>789</fpage>&#x2013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.8b00011</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorma Momo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A metal&#x2013;organic framework nanocomposite with oxidation and near-infrared light cascade response for bacterial photothermal inactivation</article-title>. <source>Front. Chem.</source> <volume>10</volume>, <fpage>1044931</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2022.1044931</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yeow</surname>
<given-names>E. K. L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Increasing antibiotic activity by rapid bioorthogonal conjugation of drug to resistant bacteria using an upconverted light-activated photocatalyst</article-title>. <source>J. Mater. Chem. B</source> <volume>9</volume>, <fpage>3136</fpage>&#x2013;<lpage>3142</lpage>. <pub-id pub-id-type="doi">10.1039/d0tb02568b</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Using near-infrared I/II light to regulate the performance of nanozymes</article-title>. <source>J. Analysis Test.</source> <volume>7</volume>, <fpage>272</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1007/s41664-023-00257-z</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Carbon dots enhanced gelatin/chitosan bio-nanocomposite packaging film for perishable foods</article-title>. <source>Chin. Chem. Lett.</source> <volume>33</volume>, <fpage>4577</fpage>&#x2013;<lpage>4582</lpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2022.03.048</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Polyhexamethylene biguanide chemically modified cotton with desirable hemostatic, inflammation-reducing, intrinsic antibacterial property for infected wound healing</article-title>. <source>Chin. Chem. Lett.</source> <volume>33</volume>, <fpage>2975</fpage>&#x2013;<lpage>2981</lpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2021.12.086</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Near-infrared light brightens bacterial disinfection: recent progress and perspectives</article-title>. <source>ACS Appl. Bio Mater.</source> <volume>4</volume>, <fpage>3937</fpage>&#x2013;<lpage>3961</lpage>. <pub-id pub-id-type="doi">10.1021/acsabm.0c01341</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bing</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A DNase-mimetic artificial enzyme for the eradication of drug-resistant bacterial biofilm infections</article-title>. <source>Nanoscale</source> <volume>14</volume>, <fpage>2676</fpage>&#x2013;<lpage>2685</lpage>. <pub-id pub-id-type="doi">10.1039/d1nr07629a</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Nanoparticles-mediated ion channels manipulation: from their membrane interactions to bioapplications</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>195</volume>, <fpage>114763</fpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2023.114763</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikuta</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Swetschinski</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Robles Aguilar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sharara</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mestrovic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A. P.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet</source> <volume>400</volume>, <fpage>2221</fpage>&#x2013;<lpage>2248</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(22)02185-7</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Orthogonal light-triggered multiple effects based on photochromic nanoparticles for DNA cleavage and beyond</article-title>. <source>J. Mater. Chem. B</source> <volume>11</volume>, <fpage>2367</fpage>&#x2013;<lpage>2376</lpage>. <pub-id pub-id-type="doi">10.1039/d2tb02638d</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Peptide hydrogel based sponge patch for wound infection treatment</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>10</volume>, <fpage>1066306</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2022.1066306</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Hyaluronic acid-methacrylic anhydride/polyhexamethylene biguanide hybrid hydrogel with antibacterial and proangiogenic functions for diabetic wound repair</article-title>. <source>Chin. Chem. Lett.</source> <volume>33</volume>, <fpage>5030</fpage>&#x2013;<lpage>5034</lpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2022.03.116</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>A highly sensitive electrochemical cytosensor based on a triple signal amplification strategy using both nanozyme and DNAzyme</article-title>. <source>J. Mater. Chem. B</source> <volume>10</volume>, <fpage>700</fpage>&#x2013;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1039/d1tb02545g</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Nanozymes as efficient tools for catalytic therapeutics</article-title>. <source>VIEW</source> <volume>3</volume>, <fpage>20200147</fpage>. <pub-id pub-id-type="doi">10.1002/viw.20200147</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makabenta</surname>
<given-names>J. M. V.</given-names>
</name>
<name>
<surname>Nabawy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Schmidt-Malan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rotello</surname>
<given-names>V. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume>, <fpage>23</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-020-0420-1</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>C. J. L.</given-names>
</name>
<name>
<surname>Ikuta</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Sharara</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Swetschinski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Robles Aguilar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source> <volume>399</volume>, <fpage>629</fpage>&#x2013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(21)02724-0</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Photomodulated nanozyme used for a gram-selective antimicrobial</article-title>. <source>Chem. Mater.</source> <volume>30</volume>, <fpage>7027</fpage>&#x2013;<lpage>7033</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemmater.8b02365</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Antibody mimics as bio-orthogonal catalysts for highly selective bacterial recognition and antimicrobial therapy</article-title>. <source>ACS Nano</source> <volume>15</volume>, <fpage>15841</fpage>&#x2013;<lpage>15849</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.1c03387</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Bio-inspired bimetallic enzyme mimics as bio-orthogonal catalysts for enhanced bacterial capture and inhibition</article-title>. <source>Chem. Mater.</source> <volume>33</volume>, <fpage>8052</fpage>&#x2013;<lpage>8058</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemmater.1c02469</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Colorimetric band-aids for point-of-care sensing and treating bacterial infection</article-title>. <source>ACS Central Sci.</source> <volume>6</volume>, <fpage>207</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.9b01104</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bing</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Functionalized antibacterial peptide with DNA cleavage activity for enhanced bacterial disinfection</article-title>. <source>Colloids Surfaces B Biointerfaces</source> <volume>228</volume>, <fpage>113412</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2023.113412</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A hybrid nano-assembly with synergistically promoting photothermal and catalytic radical activity for antibacterial therapy</article-title>. <source>Chin. Chem. Lett.</source> <volume>33</volume>, <fpage>4605</fpage>&#x2013;<lpage>4609</lpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2022.03.076</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Upputuri</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pramanik</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy</article-title>. <source>ACS Nano</source> <volume>13</volume>, <fpage>5816</fpage>&#x2013;<lpage>5825</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.9b01411</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Self-assembly multifunctional DNA tetrahedron for efficient elimination of antibiotic-resistant bacteria</article-title>. <source>Aggregate</source>, <fpage>e402</fpage>. <pub-id pub-id-type="doi">10.1002/agt2.402</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yeow</surname>
<given-names>E. K. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Exploiting the upconversion luminescence, Lewis acid catalytic and photothermal properties of lanthanide-based nanomaterials for chemical and polymerization reactions</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>24</volume>, <fpage>11455</fpage>&#x2013;<lpage>11470</lpage>. <pub-id pub-id-type="doi">10.1039/d2cp00560c</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Malmsten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rotello</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Zboril</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Antibacterial nanomaterials: mechanisms, impacts on antimicrobial resistance and design principles</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>62</volume>, <fpage>e202217345</fpage>. <pub-id pub-id-type="doi">10.1002/anie.202217345</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>HSA shrinkage optimizes the photostability of embedded dyes fundamentally to amplify their efficiency as photothermal materials</article-title>. <source>Chin. Chem. Lett.</source>, <fpage>109223</fpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2023.109223</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Graphene enhanced &#x3b1;-MnO2 for photothermal catalytic decomposition of carcinogen formaldehyde</article-title>. <source>Chin. Chem. Lett.</source> <volume>33</volume>, <fpage>4771</fpage>&#x2013;<lpage>4775</lpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2021.12.085</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cutting-edge advancements of nanomaterials for medi-translatable noninvasive theranostic modalities</article-title>. <source>VIEW</source> <volume>2</volume>, <fpage>20200144</fpage>. <pub-id pub-id-type="doi">10.1002/viw.20200144</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Deciphering the high-carbonization-temperature triggered enzymatic activity of wool-derived N, S-co-doped carbon nanosheets</article-title>. <source>Chin. Chem. Lett.</source> <volume>35</volume>, <fpage>109080</fpage>. <pub-id pub-id-type="doi">10.1016/j.cclet.2023.109080</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Near-infrared light-activatable melanized paclitaxel nano&#x2013;self-assemblies for synergistic anti-tumor therapy</article-title>. <source>J. Analysis Test.</source> <volume>7</volume>, <fpage>204</fpage>&#x2013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1007/s41664-023-00262-2</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>